Document is current
Any future updates will be listed below
-
Authors
Hirniak, Sam https://orcid.org/0009-0009-9719-6508
Edginton, Andrea N.
Iorio, Alfonso
Wong, William W. L.
-
Funding
Funding for this research was provided by:
University of Waterloo, School of Pharmacy (Intradisciplinary Seed Fund)
- License Information
-
More Information
Article History
Accepted: 10 March 2025
First Online: 1 April 2025
Declarations
:
: Ethics approval was granted by UW REB # 44471 and #44100.
: S Hirniak: No conflicts to declare. A Edginton: No conflicts to declare. A Iorio: McMaster University (the institution where A Iorio is based) has received project-based funding via research or service agreements within the past 36 months from: Bayer, Biomarin, CSL, Freeline, Grifols, Novo Nordisk, Octapharma, Pfizer, Roche, Sanofi, Sobi, Spark, Takeda, Uniqure. None were received for this project. W Wong: Has received consulting fees from Hemolytic Inc from Jan 3rd, 2024-Jan 31st 2024.
